[The effect of kallikrein on sperm motility (author's transl)].
作者信息
Lunglmayr G
出版信息
Wien Klin Wochenschr. 1976 Nov 12;88(21):709-11.
PMID:1007281
Abstract
The effect of kallikrein (240 KE/week i.m. or 600 KE/day orally) on the sperm count, sperm motility and morphology was investigated in 27 patients with pathological ejaculate findings. Kallikrein was administered over a period of 9 to 12 weeks. A significant increase in sperm motility was observed in patients with asthenospermia. No influence was noted on the ejaculate findings in patients with oligospermia. Interference between the kallikrein-kinin system and sperm motility is postulated.
摘要
相似文献
1
[The effect of kallikrein on sperm motility (author's transl)].
Wien Klin Wochenschr. 1976 Nov 12;88(21):709-11.
2
[Therapeutic application of kallikrein in idiopathic oligo- and asthenozoospermia (author's transl)].激肽释放酶在特发性少精子症和弱精子症中的治疗应用（作者译）
Wien Med Wochenschr. 1981 Aug 31;131(15-16):401-3.
3
[Clinical evaluation of kallikrein in male infertility].[激肽释放酶在男性不育症中的临床评估]
Hinyokika Kiyo. 1986 Sep;32(9):1313-8.
4
Improvement of sperm motility in patients with asthenozoospermia by kallikrein treatment.
Int J Fertil. 1975;20(1):61-3.
5
[Therapy of male fertility disorders with kallikrein].用激肽释放酶治疗男性生育障碍
Dtsch Med Wochenschr. 1976 Nov 26;101(48):1773-8. doi: 10.1055/s-0028-1104338.
6
[First results of parenteral treatment of male fertility disorders using kallikrein: oligozoospermia].
Hautarzt. 1975 Oct;26(10):541-2.
7
[Initial results in the treatment of male fertility disorders with kallikrein: asthenozoospermia].[用激肽释放酶治疗男性生育障碍的初步结果：弱精子症]
Hautarzt. 1975 Aug;26(8):430-2.
8
[Peroral kallikrein therapy for male infertility--comparison between smokers and non-smokers].
Andrologia. 1983;15 Spec No:515-22.
9
[Oral kallikrein-therapy of asthenozoospermia].
Fortschr Med. 1977 Sep 15;95(34):2102-5.
10
[Studies on the treatment of male infertility with kallikrein].[用激肽释放酶治疗男性不育症的研究]
Z Hautkr. 1975 Dec 15;50(24):1003-12.
Zotero 插件